BACKGROUND: Atopic dermatitis is a chronically relapsing inflammatory skin condition that is burdensome for individuals with the disease, their families, and for society as a whole. OBJECTIVES: The purpose of this review was to provide a broad overview of the burden of atopic dermatitis, including quality of life and its associated complications. METHODS AND RESULTS: This article was divided into four main sections: (1) atopic dermatitis prevalence, persistence, and population-level burden; (2) burden of atopic dermatitis for individuals and their families; (3) medical complications and comorbidities of atopic dermatitis; and (4) assessment of the burden of atopic dermatitis in clinical practice. CONCLUSION: Having an understanding of the burden of atopic dermatitis is important for clinicians as they assess and manage atopic dermatitis in the clinical setting.
BACKGROUND:Atopic dermatitis is a chronically relapsing inflammatory skin condition that is burdensome for individuals with the disease, their families, and for society as a whole. OBJECTIVES: The purpose of this review was to provide a broad overview of the burden of atopic dermatitis, including quality of life and its associated complications. METHODS AND RESULTS: This article was divided into four main sections: (1) atopic dermatitis prevalence, persistence, and population-level burden; (2) burden of atopic dermatitis for individuals and their families; (3) medical complications and comorbidities of atopic dermatitis; and (4) assessment of the burden of atopic dermatitis in clinical practice. CONCLUSION: Having an understanding of the burden of atopic dermatitis is important for clinicians as they assess and manage atopic dermatitis in the clinical setting.
Authors: Emma Guttman-Yassky; Patrick M Brunner; Avidan U Neumann; Saakshi Khattri; Ana B Pavel; Kunal Malik; Giselle K Singer; Danielle Baum; Patricia Gilleaudeau; Mary Sullivan-Whalen; Sharon Rose; Shelbi Jim On; Xuan Li; Judilyn Fuentes-Duculan; Yeriel Estrada; Sandra Garcet; Claudia Traidl-Hoffmann; James G Krueger; Mark G Lebwohl Journal: J Am Acad Dermatol Date: 2018-01-17 Impact factor: 11.527